Physician profile

Jacob Parnell

Internal Medicine · Nashville, TN

NPI 1144674565

$7,985.41

in general payments reported to CMS, 2019-2025

31 companies · $1,673 in 2025

The $1,673 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,866.42

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Pfizer INC. $1,707.55 2021-2025
Novo Nordisk INC $1,469.11 2020-2025 Rybelsus, Ozempic, Wegovy
Lilly USA, LLC $726.13 2021-2025 Mounjaro, Jardiance, Zepbound
Abbvie INC. $648.46 2021-2025
Glaxosmithkline, LLC. $502.55 2022-2025 Trelegy Ellipta, Arexvy, Shingrix
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $434.58 2021-2025 Xifaxan
Amgen INC. $289.74 2021-2025 Repatha, Otezla, Repatha
Janssen Pharmaceuticals, INC $286.11 2021-2024 Xarelto, Spravato
Boehringer Ingelheim Pharmaceuticals, INC. $240.18 2021-2025 Jardiance, Ofev
Abbott Laboratories $236.88 2022-2025 Freestyle Libre 3
Exact Sciences Corporation $195.42 2024-2025 Cologuard Collection Kit
Astellas Pharma US INC $173.40 2023-2025 Veozah, Myrbetriq
Sanofi-Aventis U.S. LLC $146.43 2021-2025
Phathom Pharmaceuticals, INC. $106.19 2024-2025 Voquezna
Novartis Pharmaceuticals Corporation $99.41 2022-2023
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $95.09 2021-2022
Aimmune Therapeutics, INC. $90.71 2024-2025 Zenpep
Astrazeneca Pharmaceuticals LP $83.78 2024-2025 Farxiga, Airsupra, Breztri
Biohaven Pharmaceutical Holding Company LTD. $68.70 2022
Takeda Pharmaceuticals U.S.A., INC. $62.11 2021-2022
Shield Therapeutics INC $47.56 2024-2025
Sumitomo Pharma America, INC. $46.44 2024-2025 Gemtesa
Inspire Medical Systems, INC. $44.13 2024 Inspire
Otsuka America Pharmaceutical, INC. $41.23 2024-2025 Rexulti
Cequr Corporation $32.03 2025 Cequr Simplicity
Dynavax Technologies Corporation $21.04 2023 Heplisav-B
Nestle Healthcare Nutrition INC. $20.88 2021
Biohaven Pharmaceuticals, INC. $19.07 2021
Philips North America LLC $18.22 2024 (Ck7) Extended Holter
Eisai INC. $16.99 2022
Alexion Pharmaceuticals, INC. $15.29 2025 Strensiq

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jacob Parnell

$7,985.41

in general payments reported 2019-2025

Years
2020-2025
Top company
Pfizer INC.
Context
The $1,673 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/7529329/jacob-parnell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.